Searched for
VENTURE CAPITAL IN BIOTECH
Kiran Mazumdar-Shaw's Immuneel Therapeutics raises Rs 100 crore from Singularity AMC, Rainmatter, othersThe Bengaluru-based company makes CAR-T therapy, a form of cancer treatment where a patient’s own immune cells are taken out, trained in a ...- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- H-1B chill sets in; Flipkart doubles down on ShopsyUS demand for H-1B visas has slumped to a seven-year low amid steeper costs and Trump-era policy shifts. This and more in today’s ETtech To...
- VCs eye deeptech fund launches to leverage RDI capitalSector-agnostic VC firms Kalaari Capital and Blue Ashva Capital are among those exploring new deeptech-focussed vehicles amid rising invest...
- Biotech startup StrainX Bioworks raises $13 million from Prime Venture, Leo Capital, othersStrainX Bioworks, a synthetic biology and precision fermentation startup, has raised $13 million to advance its biotechnology platform. The...
- Shastra VC launches $100 million fund to back deeptech, AI startupsThe Bengaluru-based firm said the new vehicle will invest between $500,000 and $3 million in IP-led firms across these sectors. The launch ...
- Cybersecurity firm Exaforce raises $125 million from HarbourVest, Peak XV, Khosla VenturesCybersecurity firm Exaforce secures $125 million in funding. This capital will enhance its AI-SOC platform and global expansion. The compan...
- US CEOs seek China business gains from Trump-Xi summitAmerican business leaders are heading to China for a summit with President Xi Jinping. They aim to resolve ongoing business challenges and ...
- US stocks today: Space analytics firm HawkEye 360 valued at $3.15 billion after NYSE debutHawkEye 360's stock surged 30% on its Thursday debut, reaching a $3.15 billion valuation after raising $416 million in its U.S. IPO. The de...
- Deeptech bets heat up; Paytm, PB Fintech, Meesho earningsHappy Thursday! VCs are doubling down on India’s deeptech, with early-stage bets leading the charge. This and more in today’s ETtech Mornin...
- Early-stage tech draws VC interest across aviation, biotech, precision manufacturingInvestors are prioritising smaller, early-stage deals in deeptech sectors like AI, healthcare, and precision manufacturing, shying away fro...
- The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
- Claire Mazumdar: A silent force behind a $1.6 billion firm may write Biocon's future scriptsBiocon founder Kiran Mazumdar-Shaw has named her niece, Claire Mazumdar, as her successor. Claire Mazumdar, a successful CEO of Bicara Ther...
- From FAANG to BATMMAAN: the new acronym driving global tech investing, says Niteen DongareGlobal investors are shifting focus from FAANG and Magnificent 7 to broader innovation, embracing the BATMMAAN acronym for AI, semiconducto...
- Rupee slide boosts IT; Gupshup’s valuation markdownThe rupee’s sharp slide could give IT firms a surprise Q4 bump. This and more in today’s ETtech Top 5.
- Faster capital deployment, government partnerships could move needle for biotech: StartupsThe Biotechnology Industry Research Assistance Council (BIRAC) launched the fund on February 13 to bridge the funding gap between laborator...
- Lifesciences fund IXP launches maiden Rs 200-crore fund to fuel biotech innovationThe IXP Lifesciences Catalyst Fund has a greenshoe option of Rs 100 crore with an investment horizon of 3-5 years targeting an IRR of 22 pe...
- Biopharma company Theramyt Novobiologics raises Rs 27.5 croreAarin Capital, Accel Partners, IDG Ventures as well as Karnataka state government-backed KITVEN have invested Rs 27.5 crore in Theramyt Nov...
- Biotech sector faces challenge of getting VC funding: ExpertsIndia's biotechnology industry is facing huge challenge of attracting venture capital.
- State to hardsell biotech cos to foreign investorsThe Maharashtra state government will extend its hand-holding services for start-up companies in the biotechnology field by recommending th...
Load More
